Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma
, , , , y
05 sept 2025
Acerca de este artículo
Publicado en línea: 05 sept 2025
Páginas: 403 - 411
Recibido: 15 jun 2025
Aceptado: 19 jul 2025
DOI: https://doi.org/10.2478/raon-2025-0049
Palabras clave
© 2025 Matic Setina et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Setina, Matic
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Setina, Eva
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Doljak, Ziga
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Goricar, Katja
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Dolzan, Vita
Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Kovac, Viljem
Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Institute of Oncology LjubljanaLjubljana, Slovenia